🇺🇸 glinide in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 9

Most-reported reactions

1. Abdominal Pain — 1 report (11.11%)
2. Bronchitis — 1 report (11.11%)
3. Diabetes Mellitus — 1 report (11.11%)
4. Drug Ineffective — 1 report (11.11%)
5. Liver Transplant Rejection — 1 report (11.11%)
6. Pemphigoid — 1 report (11.11%)
7. Renal Failure — 1 report (11.11%)
8. Skin Lesion — 1 report (11.11%)
9. Visual Acuity Reduced — 1 report (11.11%)

Source database →

Frequently asked questions

Is glinide approved in United States?

glinide does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for glinide in United States?

Tanabe Pharma Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.